Literature DB >> 5413504

Papilloma of the urinary bladder.

R I Lerman, R V Hutter, W F Whitmore.   

Abstract

Entities:  

Mesh：

Year:  1970        PMID： 5413504     DOI： 10.1002/1097-0142(197002)25:2<333::aid-cncr2820250209>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  7 in total

1.  The prophylactic use of Thio-TEPA, an adjuvant in the treatment of bladder tumours.

Authors:  W Dobrzecki; A Kaczmarek
Journal:  Int Urol Nephrol       Date:  1977       Impact factor: 2.370

Review 2.  Chemotherapy in the management of bladder tumours.

Authors:  W F Whitmore; A Yagoda
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

3.  Intravesical treatment of bladder cancer with recombinant human interferon-beta. Intravesical GKT-beta Chemotherapy Research Group.

Authors:  T Niijima
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 4.  Intravesical therapy in the management of superficial transitional cell carcinoma of the bladder: the experience of the EORTC GU Group.

Authors:  D Newling
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

5.  Early adjuvant adriamycin in superficial bladder carcinoma.

Authors:  C C Schulman; L J Denis; W Oosterlinck; W De Sy; M Chantrie; C Bouffioux; P J Van Cangh; P Van Erps
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

6.  Stages of transformation in the development of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced transitional cell carcinomas in the urinary bladder of rats.

Authors:  E Kunze; A Schauer; S Schatt
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976

Review 7.  Biologic response modifiers in the management of superficial bladder cancer.

Authors:  S Serels; J Fleischmann
Journal:  World J Urol       Date:  1997       Impact factor: 3.661
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.